MAP
Moody Aldrich Partners Portfolio holdings
AUM
$517M
This Quarter Return
+11.9%
1 Year Return
+38.15%
3 Year Return
+181.18%
5 Year Return
+335.56%
10 Year Return
–
AUM
$347M
AUM Growth
+$347M
(+23%)
Cap. Flow
+$53.4M
Cap. Flow
% of AUM
15.4%
Top 10 Holdings %
Top 10 Hldgs %
20.54%
Holding
122
New
27
Increased
57
Reduced
22
Closed
16
Top Buys
| 1 |
Green Dot
GDOT
|
$7.67M |
| 2 |
LHCG
LHC Group LLC
LHCG
|
$5.79M |
| 3 |
Avanos Medical
AVNS
|
$5.7M |
| 4 |
INXN
Interxion Holding N.V.
INXN
|
$5.09M |
| 5 |
HubSpot
HUBS
|
$4.38M |
Top Sells
| 1 |
AMED
Amedisys
AMED
|
$5.68M |
| 2 |
Fair Isaac
FICO
|
$4.62M |
| 3 |
KMG
KMG Chemicals Inc
KMG
|
$4.35M |
| 4 |
STMP
Stamps.com, Inc.
STMP
|
$4.13M |
| 5 |
Heartland Express
HTLD
|
$3.34M |
Sector Composition
| 1 | Healthcare | 17.34% |
| 2 | Financials | 16.69% |
| 3 | Technology | 12.16% |
| 4 | Industrials | 12.11% |
| 5 | Consumer Discretionary | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
American Woodmark
AMWD
$922M
| $2.15M | 0.62% |
27,389
+4,215
| +18% | +$331K |
|
77
FibroGen
FGEN
$48.4M
| $2.06M | 0.59% |
33,822
+5,223
| +18% | +$317K |
|
78
CONMED
CNMD
$1.64B
| $1.93M | 0.56% |
24,387
+3,941
| +19% | +$312K |
|
79
Acadia Pharmaceuticals
ACAD
$4.34B
| $1.93M | 0.56% |
+92,885
| New | +$1.93M |
|
80
Azenta
AZTA
$1.35B
| $1.81M | 0.52% |
51,740
+10,829
| +26% | +$379K |
|
81
Agios Pharmaceuticals
AGIO
$2.36B
| $1.77M | 0.51% |
22,938
+3,579
| +18% | +$276K |
|
82
Semtech
SMTC
$5.03B
| $1.72M | 0.5% |
+30,954
| New | +$1.72M |
|
83
Fate Therapeutics
FATE
$115M
| $1.61M | 0.46% |
98,993
+15,614
| +19% | +$254K |
|
|
PDCE
84
DELISTED
PDC Energy, Inc.
PDCE
| $1.5M | 0.43% |
30,644
+5,474
| +22% | +$268K |
|
85
Xencor
XNCR
$594M
| $1.47M | 0.42% |
37,598
-32,511
| -46% | -$1.27M |
|
|
AMRN
86
Amarin Corp
AMRN
$311M
| $1.31M | 0.38% |
+80,621
| New | +$1.31M |
|
|
SPPI
87
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $1.19M | 0.34% |
70,935
+4,437
| +7% | +$74.6K |
|
88
UroGen Pharma
URGN
$896M
| $860K | 0.25% |
+18,200
| New | +$860K |
|
89
Bio-Techne
TECH
$8.3B
| $451K | 0.13% |
2,212
-120
| -5% | -$24.5K |
|
90
Jack Henry & Associates
JKHY
$11.8B
| $316K | 0.09% |
1,971
-105
| -5% | -$16.8K |
|
|
SIVB
91
DELISTED
SVB Financial Group
SIVB
| $281K | 0.08% |
905
-46
| -5% | -$14.3K |
|
92
Broadridge
BR
$29.3B
| $278K | 0.08% |
2,109
-135
| -6% | -$17.8K |
|
93
Alliance Resource Partners
ARLP
$2.95B
| $248K | 0.07% |
+12,137
| New | +$248K |
|
94
Assured Guaranty
AGO
$3.89B
| $248K | 0.07% |
+5,862
| New | +$248K |
|
95
AllianceBernstein
AB
$4.37B
| $242K | 0.07% |
+7,958
| New | +$242K |
|
96
TransUnion
TRU
$16.8B
| $240K | 0.07% |
3,255
-175
| -5% | -$12.9K |
|
97
HEICO Class A
HEI.A
$34.9B
| $230K | 0.07% |
+3,046
| New | +$230K |
|
98
West Pharmaceutical
WST
$17.9B
| $224K | 0.06% |
+1,817
| New | +$224K |
|
99
Target
TGT
$42B
| $223K | 0.06% |
+2,533
| New | +$223K |
|
100
Sun Communities
SUI
$15.7B
| $219K | 0.06% |
2,156
-125
| -5% | -$12.7K |
|